| Dr Glenn David Burns, MD | |
|
88 Mdg, 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 | |
| (937) 257-8838 | |
| Not Available |
| Full Name | Dr Glenn David Burns |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 88 Mdg, Wright Patterson Afb, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417916487 | NPI | - | NPPES |
| 010263026 | Medicaid | VA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center | San antonio, TX | Hospital |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Travis County Emergency Physicians Pa | 0840289468 | 253 |
News Archive
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
A study suggests that the recent rapid uptake of intensity-modulated radiotherapy for prostate cancer in the USA has been driven by urologists with financial conflicts of interest.
The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.
Although combination antiretroviral therapy (cART) has improved survival of patients infected with HIV and has reduced the incidence of severe neurologic complications, almost half of cART-treated HIV patients experience some degree of neurocognitive impairment (neuroHIV).
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 1 days ago
| Entity Name | Third Coast Emergency Physicians Southwest Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497793475 PECOS PAC ID: 6800794447 Enrollment ID: O20031222000126 |
News Archive
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
A study suggests that the recent rapid uptake of intensity-modulated radiotherapy for prostate cancer in the USA has been driven by urologists with financial conflicts of interest.
The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.
Although combination antiretroviral therapy (cART) has improved survival of patients infected with HIV and has reduced the incidence of severe neurologic complications, almost half of cART-treated HIV patients experience some degree of neurocognitive impairment (neuroHIV).
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 1 days ago
| Entity Name | Travis County Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962440933 PECOS PAC ID: 0840289468 Enrollment ID: O20040510000492 |
News Archive
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
A study suggests that the recent rapid uptake of intensity-modulated radiotherapy for prostate cancer in the USA has been driven by urologists with financial conflicts of interest.
The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.
Although combination antiretroviral therapy (cART) has improved survival of patients infected with HIV and has reduced the incidence of severe neurologic complications, almost half of cART-treated HIV patients experience some degree of neurocognitive impairment (neuroHIV).
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn David Burns, MD 3963 Mclean Rd, Franklin, OH 45005-4755 Ph: (202) 316-6929 | Dr Glenn David Burns, MD 88 Mdg, 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Ph: (937) 257-8838 |
News Archive
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
A study suggests that the recent rapid uptake of intensity-modulated radiotherapy for prostate cancer in the USA has been driven by urologists with financial conflicts of interest.
The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.
Although combination antiretroviral therapy (cART) has improved survival of patients infected with HIV and has reduced the incidence of severe neurologic complications, almost half of cART-treated HIV patients experience some degree of neurocognitive impairment (neuroHIV).
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 1 days ago
Dr. Eric Michael Mozeleski, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-0770 | |
Nora Gerson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-3203 | |
Jared C Vaughan, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-0837 | |
James Michael Manley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4881 Sugar Maple Dr, 88 Mdg/sgoe, Wright Patterson Afb, OH 45433 Phone: 720-323-5725 | |
Jeffrey Nathan Harris, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-9612 | |
Joseph Inhofer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-0770 | |
Dr. Roy Lee Johnson Iii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-0770 |